Researchers have found in a new research that Serum creatinine levels, pre-revascularization peak systolic velocity of the ...

A new study could lead to more widespread use of imaging technique to improve survival and prevent complications.

Terumo Neuro (formerly MicroVention) announced today that it received FDA premarket approval (PMA) for its Carotid Stent ...

Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than ...

The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery ...

Coronary artery bypass grafting is a more invasive procedure where surgeons use blood vessels from another part of the body to create a new route for blood to flow around blocked arteries. It is ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid st ...

The advanced technique, successfully implemented at KFSHRC in Riyadh and Jeddah, uses a bioresorbable stent inserted into narrowed or blocked vessels to temporarily restore blood flow. After serving ...

The global absorbable heart stent market, valued at US$ 307.1 million in 2022, is projected to experience substantial growth in the coming years. With a forecasted compound annual growth rate (CAGR) ...

Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced that their Carotid Stent System has received Premarket Approval (PMA) ...